Alterola Biotech, Inc. (ABTI)
OTCMKTS · Delayed Price · Currency is USD
0.2000
+0.1998 (99,900.00%)
Oct 31, 2025, 3:00 PM EST
Alterola Biotech Market Cap
Alterola Biotech has a market cap or net worth of $296.25 thousand as of November 4, 2025. Its market cap has decreased by -99.53% in one year.
Market Cap
296.25K
Enterprise Value
2.37M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.20
Market Cap Chart
Since June 21, 2021, Alterola Biotech's market cap has decreased from 1.46B to 296.25K, a decrease of -99.98%. That is a compound annual growth rate of -86.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 296.25K | -93.23% |
| Dec 24, 2024 | 4.38M | -10.93% |
| Dec 19, 2023 | 4.92M | -87.82% |
| Dec 30, 2022 | 40.35M | -63.75% |
| Dec 31, 2021 | 111.33M | -92.35% |
| Jun 21, 2021 | 1.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 577.78M |
| Northwest Biotherapeutics | 390.01M |
| Silence Therapeutics | 312.22M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |